Coronary

View the latest content related to this topic

News Daily News

Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD

High fat volume was linked to plaque presence and progression, but more work is needed to clarify clinical use.

Yael L. Maxwell

March 24, 2026

Slides

See all

Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

Presentation ACC 2026

Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Randomized Trial

Presenter: Ajay J. Kirtane

March 29, 2026

Presentation ACC 2026

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Presenter: Michiel Voskuil

March 29, 2026

Presentation ACC 2026

Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization: the FAST III Trial

Presenter: Joost Daemen

March 29, 2026

News

See all

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

By Todd Neale

April 02, 2026

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

By Michael O'Riordan

April 01, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

By Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

By Michael O'Riordan

March 30, 2026

News Conference News ACC 2026

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

By Yael L. Maxwell

March 30, 2026

CRT 2026

March 7

March 10, 2026

THT 2026

March 2

March 04, 2026

EAPCI 2026

February 19

February 20, 2026

Videos on This Topic

See all

Video On Record

Advertisement

Coronary

Epicardial Fat Shows Promise as a Clinical Risk Factor for CAD

Advertisement

Slides

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment: The ALL-RISE Randomized Trial

Deferral of PCI in Patients Undergoing TAVI (PRO-TAVI): an Investigator-Initiated, Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization: the FAST III Trial

News

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

TCTMD’s Top 10 Most Popular Stories for March 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Deferring PCI Until After TAVI Safe, Reduces Bleeding: PRO-TAVI

More on This Topic

Conference Coverage

CRT 2026

THT 2026

EAPCI 2026

Videos on This Topic

On Record: How Does CABG Continue to Be Optimized?

Advertisement

Coronary

Advertisement

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content